The Lancet Group

The Lancet Respiratory Medicine in conversation with

Health EN ↓ 63 episodes

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

Author

The Lancet Group

Episodes

Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma 10.07.2021 13:17

Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00226-5/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup...

Paul Verweij on COVID-19 associated aspergillosis 26.05.2021 6:36

Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00138-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/...

Ignacio Rubio on COVID-19 pathophysiology and phenotypes 17.05.2021 9:19

Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00218-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.c...

Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia 14.05.2021 9:54

Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00207-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmed...

Fan Chung on chronic cough and long COVID 11.05.2021 11:32

Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00125-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/th...

Mepolizumab and the treatment of chronic rhinosinusitis 16.04.2021 7:18

Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https...

Inhaled budesonide in the treatment of early COVID-19 15.04.2021 10:24

Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicalj...

Tocilizumab and COVID-19 05.03.2021 5:45

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram....

Interferon treatment and COVID-19 06.02.2021 6:34

Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn...

Evaluating deterioration in patients with acute COVID-19 12.01.2021 8:29

Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljourna...

Treatment options in patients with systemic sclerosis-associated interstitial lung disease 05.01.2021 15:45

Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30458-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ h...

COVID-19 and severe influenza 18.12.2020 8:08

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

The second wave and homeless populations 11.11.2020 7:57

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv